PLA2G7 and hepatocellular carcinoma: For example, in hepatocellular carcinoma, PLA2G7 promotes cancer cell development through the STAT1/PD-L1 axis, and high expression of PLA2G7 in macrophages can promote immunosuppression by adversely affecting the activation of CD8+ T cells [23, 24].